In addition, genetic classifications including BRCA1 DNA repair associated (BRCA1), BRCA2 DNA repair associated (BRCA2), and tumor protein p53 (TP53) mutations can provide for more detailed description of the tumor’s molecular biology, which can improve disease prognosis [37,38]. The gene discussed is BRCA1; the disease is neoplasm.